Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals.

Chang Chee TaoSiti Mallissa Mohd ShariffNur Suriana Abu BakarNasiha Sufina RamzuzzamanChun Kiat LimEddy Yew Joe LimPeng Seng OngJie Min LeeAie Yen TanSiti Fatimah KamisWei Mun LiewYuet Man LowDoris GeorgeJames Yau Hon VooHoo Seng TanPhilip RajanShaun Wen Huey Lee

Published in: Journal of pharmaceutical policy and practice (2023)

Nearly, one in three older adults with COVID-19 had been prescribed a PIM, and the proportion of older adults with polypharmacy increased after discharge. This highlights the importance of having clinical pharmacist conducting medication reviews to identify PIMs and ensure medication appropriateness.

Keyphrases

coronavirus disease
adverse drug
sars cov
physical activity
healthcare
community dwelling
middle aged
respiratory syndrome coronavirus
randomized controlled trial
systematic review
drug induced